William J. Cople speaks at public policy conference on federalism and the pharmaceutical industry.
March 27, 2015
Law & Economics Center, George Mason University School of Law, Arlington, VA
This two and a half day program explored the economics and legal issues of the pharmaceutical industry and discussed many issues of importance to states. The conference began with foundational lectures on the economics of pharmaceutical pricing and understanding the FDA drug approval process. Conference panels examined pharmaceutical marketing, consumer protection issues under the Affordable Care Act, concerns surrounding pharmaceuticals and intellectual property, as well as counterfeit drugs and consumer health.
Firm partner William J. Cople spoke on "False Claims Act Litigation and Medicaid Fraud." His presentation featured the USAO/SDNY intervention in the FCA/qui tam litigation against Computer Sciences Corp. and New York City in the Southern District of New York. The presentation was part of an invited panel presentation on FCA Litigation, which, among others, included the head of the Medicaid Fraud Enforcement Unit for the Commonwealth of Virginia. The panel was moderated by a former Virginia Attorney General.